The U.S. Food and Drug Administration has sent a warning letter to Marlborough, Mass.-based medical technology company ...

FDA issues warning to Hologic, citing manufacturing and safety violations for BioZorb devices. Patient safety risks and reporting failures highlighted ...

Hologic is down approximately 20% from recent highs and continues to grow organically and via a series of 'bolt-on' ...

Olga Danilovic upset Jessica Pegula in the Australian Open third round to notch her third career Top 10 win and move into the ...

The stock's rise snapped a four-day losing streak.

On Wednesday, Hologic Inc (HOLX) stock saw a decline, ending the day at $68.75 which represents a decrease of $-1.45 or -2.07% from the prior close of $70.2. The stock opened at $69.97 and touched a ...

Enough evidence for jury to consider failure to warn claim Case is one of nearly two dozen Hologic faces over BioZorb Hologic Inc. can’t shake a woman’s suit alleging the medical device manufacturer ...

Hologic stopped manufacturing the device after reports of serious adverse events in patients who had the markers implanted in ...

Shares of Hologic Inc. HOLX slid 2.07% to $68.75 Wednesday, on what proved to be an all-around great trading session for the ...

With a market cap of $15.9 billion, Marlborough, Massachusetts-based Hologic, Inc. (HOLX) specializes in developing, ...

Hologic Inc. has received a warning letter from the Food and Drug Administration regarding its BioZorb product line, even ...

Shares of Hologic HOLX recorded a new 52-week low of $69.46 during Monday’s trading before finishing slightly higher at $70.29. Yesterday, the stock ended at $70.20, marking the lowest close in recent ...